NCT00106288View on ClinicalTrials.gov

Micafungin Versus AmBisome in Invasive Candidiasis and Candidemia

PHASE3CompletedINTERVENTIONAL
Enrollment

637

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions
Candidiasis
Interventions
DRUG

Micafungin

IV

DRUG

Liposomal Amphotericin B

IV

Trial Locations (37)

10021

New York

10029

New York

10032

New York

10595

Valhalla

14642

Rochester

19104

Philadelphia

19107

Philadelphia

19140

Philadelphia

27710

Durham

30322

Atlanta

32207

Jacksonville

48201

Detroit

55455

Minneapolis

60153

Maywood

60521

Hinsdale

66160

Kansas City

77030

Houston

80218

Denver

84604

Provo

92868

Orange

35294-0006

Birmingham

20010-2970

Washington D.C.

40536-0084

Lexington

21201-1595

Baltimore

02115

Boston

02211

Boston

78229-3900

San Antonio

T2N 2T9

Calgary

V6Z 1Y6

Vancouver

R3A 1R9

Winnipeg

B3H 2Y9

Halifax

L8V 1C3

Hamilton

M5S 2N9

Toronto

H1T 2M4

Montreal

H2L 4M1

Montreal

G1R 2J6

Québec

S4P OW5

Regina

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY